Cargando…
Evaluating cost-effectiveness in the management of neuroendocrine neoplasms
The rapid evolution of novel, costly therapies for neuroendocrine neoplasia (NEN) warrants formal high-quality cost-effectiveness evaluation. Costs of individual investigations and therapies are high; and examples are presented. We aimed to review the last ten years of standalone health economic eva...
Autores principales: | White, B. E., Mujica-Mota, R., Snowsill, T., Gamper, E. M., Srirajaskanthan, R., Ramage, J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346405/ https://www.ncbi.nlm.nih.gov/pubmed/33155118 http://dx.doi.org/10.1007/s11154-020-09608-y |
Ejemplares similares
-
Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2023) -
Nutritional and vitamin status in patients with neuroendocrine neoplasms
por: Clement, Dominique SVM, et al.
Publicado: (2019) -
Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England
por: Russell, Beth, et al.
Publicado: (2023) -
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
por: Basuroy, Ron, et al.
Publicado: (2012) -
Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis
por: Llewellyn, David C, et al.
Publicado: (2021)